NovoCure (NVCR) Tax Rate (2014 - 2026)

NovoCure (NVCR) posted Tax Rate of 25.75% for Q2 2026, down 848.5% sequentially from 2.71% in Q1 2026, and down 1100.0% YoY from 2.57% in Q2 2025.

NovoCure (NVCR) Tax Rate (2014 - 2026) Analysis & Trends

NovoCure has reported Tax Rate for 13 years, with the latest figure at 25.75% in Q2 2026.

Quarterly Tax Rate fell 1100.0% year-over-year to 25.75% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 2.7% (up 2303.0% YoY) and the FY2025 annual result came in at 0.02%, up 2858.0% from the prior year.
Tax Rate fell to 25.75% in Q2 2026 per NVCR's latest filing, from 2.71% in the prior quarter.
Over five years, Tax Rate peaked at 40.18% in Q4 2025 and troughed at 84.77% in Q1 2022.
A 5-year average of 17.87% and a median of 14.66% in 2025 frame the typical range for Tax Rate.
The sharpest annual moves came in 2023 and 2024: Tax Rate surged 8089 bps in 2023, then sank 4032 bps in 2024.
Over 5 years, Tax Rate stood at 14.57% in 2022, then plunged by 52 bps to 22.18% in 2023, then grew by 12 bps to 19.41% in 2024, then soared by 307 bps to 40.18% in 2025, then plunged by 164 bps to 25.75% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 25.75%, 2.71%, and 40.18% for Q2 2026, Q1 2026, and Q4 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn	39.11%
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn	18.41%
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn	31.35%
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn	14.62%
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn	53.56%
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn	21.54%
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn	17.17%
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn	-21.74%
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn	26.51%
10	NovoCure	2.06 Bn	1.62 Bn	142.48 Mn	-25.75%

Download Data